Funding for this research was provided by:
Major Research Plan (31870818)
National Natural Science Foundation of China (82000170)
National Key R&D Program of China (2017YFA0504400)
Received: 4 April 2020
Accepted: 20 October 2020
First Online: 3 November 2020
Ethics approval and consent to participate
: The clinical leukemia sample collection was approved by the First Affiliated Hospital of Sun Yat-sen University’s Protection of Human Subjects Committee. This study was conducted in accordance with the Declaration of Helsinki principles. Written informed consent was obtained from all patients participating in the study. All animals used in this study were maintained under specific pathogen-free conditions in the Laboratory Animal Center of Sun Yat-sen University. All experiments on animals were performed according to the institutional ethical guidelines for animal experiments and approved by the Institutional Animal Care and Use Committee, Sun Yat-sen University (permit No. SYSU-IACUC-2019-B594).
: Not applicable.
: The authors declare no competing financial interests.